| scholarly article | Q13442814 |
| P2093 | author name string | Timothy L Tellinghuisen | |
| Jason Treadaway | |||
| Katie L Foss | |||
| P2860 | cites work | Purification of a yeast protein kinase sharing properties with type I and type II casein kinases | Q68193837 |
| Hepatitis C: global prevalence | Q73914212 | ||
| Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321 | Q22010539 | ||
| Cellular cofactors affecting hepatitis C virus infection and replication | Q24317564 | ||
| Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication | Q24561987 | ||
| Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft | Q24600344 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| The Src Family Kinase c-Yes Is Required for Maturation of West Nile Virus Particles | Q27471553 | ||
| Quantitative Analysis of the Hepatitis C Virus Replication Complex | Q27472670 | ||
| Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication | Q27472912 | ||
| Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells | Q27473106 | ||
| Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase | Q27473147 | ||
| Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras | Q27473179 | ||
| Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons | Q27473471 | ||
| Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles | Q27477620 | ||
| c-Src protein kinase inhibitors block assembly and maturation of dengue virus | Q27478101 | ||
| Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A | Q27478481 | ||
| Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase | Q27480873 | ||
| Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions | Q27480902 | ||
| Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus | Q27481018 | ||
| Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein | Q27485314 | ||
| Expression and identification of hepatitis C virus polyprotein cleavage products | Q27486022 | ||
| Internal ribosome entry site within hepatitis C virus RNA | Q27486220 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| The lipid droplet is an important organelle for hepatitis C virus production | Q28131709 | ||
| Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence | Q29616388 | ||
| Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon | Q29619491 | ||
| An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A | Q29620628 | ||
| NMR structure and molecular dynamics of the in-plane membrane anchor of nonstructural protein 5A from bovine viral diarrhea virus | Q31032305 | ||
| Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes | Q33204253 | ||
| Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome | Q33835218 | ||
| Hepatitis C virus NS5A: tales of a promiscuous protein | Q33980571 | ||
| Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? | Q34003264 | ||
| Protein kinase CK2: a challenge to canons | Q34875408 | ||
| Order or chaos? An evaluation of the regulation of protein kinase CK2. | Q36021539 | ||
| Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein | Q38321693 | ||
| Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies. | Q39257481 | ||
| Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors | Q40196972 | ||
| Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture | Q40273957 | ||
| Tagging of NS5A expressed from a functional hepatitis C virus replicon | Q40316646 | ||
| Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. | Q40458895 | ||
| Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. | Q40478178 | ||
| The NS5A protein of hepatitis C virus is a zinc metalloprotein | Q40520544 | ||
| Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli | Q40528507 | ||
| Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. | Q40536971 | ||
| Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. | Q40837290 | ||
| Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. | Q40959885 | ||
| The Los Alamos hepatitis C sequence database | Q42987686 | ||
| Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. | Q42997783 | ||
| Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes | Q43041235 | ||
| 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. | Q45052212 | ||
| Human casein kinase II. The subunit alpha protein activates transcription of the subunit beta gene | Q48128937 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| phosphorylation | Q242736 | ||
| Hepatitis C virus | Q708693 | ||
| virion | Q1757347 | ||
| P304 | page(s) | e1000032 | |
| P577 | publication date | 2008-03-21 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein | |
| P478 | volume | 4 |
| Q37694444 | A Casein Kinase II Phosphorylation Site in AtYY1 Affects Its Activity, Stability, and Function in the ABA Response |
| Q27489795 | A Conserved Proline between Domains II and III of Hepatitis C Virus NS5A Influences both RNA Replication and Virus Assembly |
| Q35905354 | A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication |
| Q34427768 | A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses |
| Q39394432 | A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility |
| Q35531477 | A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus |
| Q36559512 | A hepatitis C virus NS5A phosphorylation site that regulates RNA replication |
| Q24320237 | A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production |
| Q47551049 | A role for domain I of the hepatitis C virus NS5A protein in virus assembly. |
| Q33520822 | A time-resolved fluorescence-resonance energy transfer assay for identifying inhibitors of hepatitis C virus core dimerization |
| Q28650908 | Advanced molecular surveillance of hepatitis C virus |
| Q37948856 | Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design |
| Q38215652 | Advances in newly developing therapy for chronic hepatitis C virus infection |
| Q42904936 | Advances in research on HCV replication and virion formation |
| Q34120165 | All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding |
| Q34506649 | Aminoterminal amphipathic α-helix AH1 of hepatitis C virus nonstructural protein 4B possesses a dual role in RNA replication and virus production |
| Q34288777 | Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems. |
| Q36592598 | Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin |
| Q33853582 | Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection |
| Q27490474 | Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles |
| Q27490193 | Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis |
| Q38544196 | Beclabuvir for the treatment of hepatitis C. |
| Q28542410 | Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S) |
| Q54245494 | Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release. |
| Q40502372 | Cell culture-adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes. |
| Q36155035 | Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus |
| Q37514366 | Cellular and molecular biology of HCV infection and hepatitis |
| Q27490303 | Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation |
| Q59351863 | Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation |
| Q42280622 | Characterizations of HCV NS5A replication complex inhibitors. |
| Q35140442 | Charged residues in hepatitis C virus NS4B are critical for multiple NS4B functions in RNA replication |
| Q26775011 | Chronic hepatitis C: This and the new era of treatment |
| Q27489790 | Cochaperone Activity of Human Butyrate-Induced Transcript 1 Facilitates Hepatitis C Virus Replication through an Hsp90-Dependent Pathway |
| Q39835772 | Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus |
| Q42980276 | Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection |
| Q35077451 | Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication |
| Q28551959 | Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A |
| Q27488788 | Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex |
| Q36373257 | Critical role of Casein kinase 2 in hepatitis C NS5A-mediated inhibition of Kv2.1 K(+) channel function |
| Q27488306 | Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus |
| Q57071775 | Current and future targets of antiviral therapy in the hepatitis C virus life cycle |
| Q38060117 | Current progress in the treatment of chronic hepatitis C. |
| Q59330226 | Cyclophilin A as a target in the treatment of cytomegalovirus infections |
| Q35385005 | Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factories |
| Q28748683 | DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A |
| Q35641053 | Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication |
| Q38286335 | Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. |
| Q24318808 | Diacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core |
| Q38466270 | Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. |
| Q34185949 | Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052 |
| Q35063336 | Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A. |
| Q42985720 | Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded |
| Q30576516 | Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection. |
| Q37263769 | Echocardiogram study to evaluate the effect of the novel hepatitis C virus NS5A inhibitor GSK2336805 on cardiac contractility in healthy subjects |
| Q36276803 | Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvir |
| Q42195777 | Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adults |
| Q37252600 | Efficiency of E2-p7 processing modulates production of infectious hepatitis C virus |
| Q35709709 | Emerging role of lipid droplets in host/pathogen interactions. |
| Q38848095 | Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection |
| Q27489037 | Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics |
| Q34107289 | Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein |
| Q22809915 | Flaviviridae Replication Organelles: Oh, What a Tangled Web We Weave |
| Q39343070 | Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A. |
| Q38256293 | Function of nonstructural 5A protein of genotype 2a in replication and infection of HCV with gene substitution |
| Q38311888 | Functional characterization of bovine viral diarrhea virus nonstructural protein 5A by reverse genetic analysis and live cell imaging |
| Q35040828 | GPS2 is required for the association of NS5A with VAP-A and hepatitis C virus replication |
| Q36760201 | Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein |
| Q35071597 | Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly |
| Q38844558 | Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. |
| Q38705916 | Grass Carp Reovirus VP41 Targets Fish MITA To Abrogate the Interferon Response |
| Q56396163 | HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A |
| Q38784494 | HCV RNA traffic and association with NS5A in living cells. |
| Q38190014 | HCV core protein and virus assembly: what we know without structures |
| Q28539751 | HCV core residues critical for infectivity are also involved in core-NS5A complex formation |
| Q56911116 | HCV replication and assembly: a play in one act |
| Q34107435 | Heat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication |
| Q34332546 | Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistance |
| Q27489514 | Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes |
| Q27488369 | Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B |
| Q40141993 | Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response |
| Q36065201 | Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase |
| Q28067295 | Hepatitis C Virus and Antiviral Drug Resistance |
| Q39621458 | Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes |
| Q34457862 | Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins |
| Q42910831 | Hepatitis C virus NS3 inhibitors: current and future perspectives |
| Q27488808 | Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain |
| Q33966987 | Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR |
| Q42281044 | Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling |
| Q24308485 | Hepatitis C virus NS5A inhibits mixed lineage kinase 3 to block apoptosis |
| Q41682315 | Hepatitis C virus NS5A protein enhances gluconeogenesis through upregulation of Akt-/JNK-PEPCK signalling pathways |
| Q38086753 | Hepatitis C virus RNA replication |
| Q38294573 | Hepatitis C virus RNA replication and assembly: living on the fat of the land |
| Q37967734 | Hepatitis C virus assembly imaging |
| Q39358973 | Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate |
| Q26801207 | Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy |
| Q27488889 | Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection |
| Q35818245 | Hepatitis C virus infection of neuroepithelioma cell lines |
| Q34792436 | Hepatitis C virus life cycle and lipid metabolism |
| Q34003758 | Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target |
| Q45373310 | Hepatitis C virus nonstructural protein 5A inhibitors: Novel target-Now for new trials and new treatment strategies |
| Q38615924 | Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy |
| Q27488905 | Hepatitis C virus replicons: dinosaurs still in business? |
| Q36580492 | Hepatitis C virus utilizes lipid droplet for production of infectious virus |
| Q34974042 | Hepatitis C virus virology and new treatment targets |
| Q37748255 | Hepatitis C virus: assembly and release of virus particles |
| Q42996860 | Hepatitis C: An unsuspected drug target |
| Q27487019 | High-Resolution Functional Profiling of Hepatitis C Virus Genome |
| Q26779128 | Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection |
| Q27468561 | Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation |
| Q93349212 | Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases |
| Q24297412 | Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly |
| Q27490539 | Identification of Hepatitis C Virus NS5A Inhibitors |
| Q34641874 | Identification of a novel phosphorylation site in hepatitis C virus NS5A |
| Q39545671 | Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry |
| Q35037141 | Identification of novel human kinases that suppress hepatitis C virus infection |
| Q38224436 | Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview |
| Q38934649 | In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A. |
| Q38195180 | Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion |
| Q28364857 | Infection Counter: Automated Quantification of in Vitro Virus Replication by Fluorescence Microscopy |
| Q34295937 | Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. |
| Q34386515 | Insights into the complexity and functionality of hepatitis C virus NS5A phosphorylation |
| Q38437734 | Interaction between Nonstructural Proteins NS4B and NS5A Is Essential for Proper NS5A Localization and Hepatitis C Virus RNA Replication |
| Q59047334 | Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer |
| Q27486780 | Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles |
| Q43100552 | Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals |
| Q34208090 | Intracellular innate immune cascades and interferon defenses that control hepatitis C virus |
| Q39227082 | Intragenic complementation of hepatitis C virus NS5A RNA replication-defective alleles |
| Q28115857 | Involvement of FKBP6 in hepatitis C virus replication |
| Q33744016 | Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production |
| Q33934312 | Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors. |
| Q37688134 | Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches |
| Q35261158 | Last stop before exit - hepatitis C assembly and release as antiviral drug targets |
| Q38793356 | Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection |
| Q24338608 | Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein |
| Q35275932 | Lipid metabolism and HCV infection |
| Q36224063 | Lipids and RNA virus replication |
| Q36810400 | Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? |
| Q39632174 | Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase |
| Q28481438 | Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity |
| Q34035703 | Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life |
| Q36978947 | Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B |
| Q34593688 | Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2. |
| Q27347838 | Molecular determinants and dynamics of hepatitis C virus secretion |
| Q35740670 | Morphogenesis of infectious hepatitis C virus particles |
| Q40040199 | NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B. |
| Q33828601 | NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly |
| Q38855634 | NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication |
| Q39641797 | Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission |
| Q35653358 | New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy |
| Q36255920 | Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver |
| Q35336114 | Nonstructural protein 5A (NS5A) and human replication protein A increase the processivity of hepatitis C virus NS5B polymerase activity in vitro |
| Q35828072 | Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb. |
| Q38152674 | Novel therapeutic approaches for hepatitis C. |
| Q37348347 | Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a. |
| Q34182392 | Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment |
| Q35115608 | Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation |
| Q36594669 | Phosphoproteomics Identified an NS5A Phosphorylation Site Involved in Hepatitis C Virus Replication |
| Q92309655 | Phosphorylated tyrosine 93 of hepatitis C virus nonstructural protein 5A is essential for interaction with host c-Src and efficient viral replication |
| Q37960427 | Phosphorylation events during viral infections provide potential therapeutic targets. |
| Q38794387 | Phosphorylation of NS5A Serine-235 is essential to hepatitis C virus RNA replication and normal replication compartment formation |
| Q38700346 | Phosphorylation of Serine 225 in Hepatitis C Virus NS5A Regulates Protein-Protein Interactions |
| Q24318654 | Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A |
| Q40334467 | Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects |
| Q41907539 | Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A |
| Q90131084 | Preclinical evaluation of Amphihevir, a first-in-class clinical Hepatitis C virus NS4B inhibitor |
| Q42978648 | Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load |
| Q27488616 | Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations |
| Q38635596 | Progress in the development of vaccines for hepatitis C virus infection |
| Q27489533 | Protein Kinase G Phosphorylates Mosquito-Borne Flavivirus NS5 |
| Q82943425 | RETRACTED ARTICLE: Bovine viral diarrhea virus nonstructural protein 5A is phosphorylated by cdc2 cyclin-dependent kinase in vitro |
| Q24317116 | Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets |
| Q24337128 | Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment |
| Q59349215 | Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy |
| Q45324832 | Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein |
| Q36073572 | Regulation of neuronal proapoptotic potassium currents by the hepatitis C virus nonstructural protein 5A. |
| Q35077458 | Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III. |
| Q60046810 | Relevance of Rab Proteins for the Life Cycle of Hepatitis C Virus |
| Q35666596 | Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor |
| Q39552847 | Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel |
| Q36558519 | Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems |
| Q38111844 | Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. |
| Q27489539 | Role of Oxysterol Binding Protein in Hepatitis C Virus infection |
| Q39723381 | Role of annexin A2 in the production of infectious hepatitis C virus particles |
| Q37621569 | Role of lipid metabolism in hepatitis C virus assembly and entry |
| Q27487337 | Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication |
| Q26745769 | Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C |
| Q37358620 | Scotomas in molecular virology and epidemiology of hepatitis C virus |
| Q40250013 | Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment |
| Q34154593 | Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy |
| Q57469882 | Sequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5A |
| Q90068221 | Serine 229 Balances the Hepatitis C Virus Nonstructural Protein NS5A between Hypo- and Hyperphosphorylated States |
| Q35491398 | Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? |
| Q24322876 | Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2 |
| Q30421625 | Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein |
| Q33878202 | Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action |
| Q27666400 | Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly |
| Q38321799 | Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors |
| Q34522481 | Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis |
| Q37006634 | The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release |
| Q40193153 | The Casein Kinase 2-Dependent Phosphorylation of NS5A Domain 3 from Hepatitis C Virus Followed by Time-Resolved NMR Spectroscopy. |
| Q30009088 | The Disordered Region of the HCV Protein NS5A: Conformational Dynamics, SH3 Binding, and Phosphorylation |
| Q33802795 | The ESCRT system is required for hepatitis C virus production |
| Q27487943 | The Hepatitis C Virus NS4B Protein Can trans-Complement Viral RNA Replication and Modulates Production of Infectious Virus |
| Q27488391 | The Marmoset Model of GB Virus B Infections: Adaptation to Host Phenotypic Variation |
| Q38847352 | The N-terminus of classical swine fever virus (CSFV) nonstructural protein 2 modulates viral genome RNA replication |
| Q63246498 | The acidic domain of the hepatitis C virus NS4A protein is required for viral assembly and envelopment through interactions with the viral E1 glycoprotein |
| Q43640359 | The identification of three sizes of core proteins during the establishment of persistent hepatitis C virus infection in vitro |
| Q37498626 | The ins and outs of hepatitis C virus entry and assembly |
| Q35597941 | The interaction between the hepatitis C proteins NS4B and NS5A is involved in viral replication |
| Q34418887 | The intraviral protein interaction network of hepatitis C virus |
| Q21131379 | The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A |
| Q33506814 | The long and winding road leading to the identification of the hepatitis C virus |
| Q38968729 | The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production |
| Q38113079 | The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection |
| Q38634755 | The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| Q35097566 | The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein |
| Q39734465 | The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization |
| Q33529510 | The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A. |
| Q38016958 | Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents |
| Q38460386 | Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy |
| Q45368519 | Triglyceride synthesis and hepatitis C virus production: identification of a novel host factor as antiviral target |
| Q37891074 | Turning hepatitis C into a real virus |
| Q39148859 | Ultrastructural and biochemical basis for hepatitis C virus morphogenesis. |
| Q30432551 | Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture |
| Q37699395 | Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. |
| Q37865821 | Unique ties between hepatitis C virus replication and intracellular lipids. |
| Q40929413 | Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir |
| Q30009166 | Vinexin β Interacts with Hepatitis C Virus NS5A, Modulating Its Hyperphosphorylation To Regulate Viral Propagation |
| Q38086754 | Virion assembly and release |
| Q36281839 | Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation. |
| Q24323080 | Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production |
| Q34711864 | hepatitis c Virus p7 is critical for capsid assembly and envelopment |
| Q27488316 | trans-Complementation of an NS2 Defect in a Late Step in Hepatitis C Virus (HCV) Particle Assembly and Maturation |
Search more.